Eli Lilly & Co. is down more than $120 billion in market value and its status as the poster child of the weight-loss drug frenzy is under threat with at least two rivals posting encouraging ...

Lilly's Mounjaro and Zepbound are only warming up. The company has several other promising drugs in its lineup and pipeline. The main concern with Lilly is its valuation. On Aug. 8, Lilly reported ...

Eli Lilly & Co. sent a wave of letters to US health care providers in recent days demanding they stop promoting copycat weight-loss drugs as supply of the company’s brand-name medicines improves.

Eli Lilly & Co.’s stock was on pace for its worst day in about three years Thursday as investors fretted about intensifying competition among obesity-drug developers. Lilly’s stock LLY was ...

On Tuesday, Eli Lilly unveiled a towering 346,000-square-foot laboratory in Boston’s Seaport District, a building that will house 500 of the company’s scientists — 300 of whom are still to ...

By redeeming these Mighty Omega codes, you’ll get some much-needed help to shorten your path to fighting mastery. If you cannot get enough of anime-inspired fighting games, visit our Bending ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

NANTERRE, France – Lilly King was on top of the world, and on top of the podium, at the Rio Olympics eight years ago. It is harder to stay there than get there. Yet one-hundredth of a second ...

Powered by Mounjaro and Zepbound, Lilly announced staggering sales and earnings growth this morning. The weight loss drug business is so good, Lilly also raised its full-year sales forecast by $3 ...

Eli Lilly and Company (NYSE: LLY) announced today that Marschall S. Runge, M.D., Ph.D. is retiring from his role as an independent director of Lilly's board of directors effective Aug. 31 ...

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare ...

Eli Lilly and Company (NYSE: LLY) announced today that Marschall S. Runge, M.D., Ph.D. is retiring from his role as an independent director of Lilly's board of directors effective Aug. 31 ...